Quality of life and discriminating power of two questionnaires in fi bromyalgia patients: Fibromyalgia impact questionnaire and medical outcomes study 36-item short-form health survey;A qualidade de vida e o poder de discriminação de dois questionários em pacientes com fi bromialgia: Fibromyalgia impact questionnaire e medical outcomes study 36-item short-form health survey

Revista Brasileira de Fisioterapia

Volumn 14, Issue 4, 2010, Pages 284-289

  Assumpção, Ana ^a   Pagano, Tatiana ^c   Matsutani, Luciana A ^b   Ferreira, Elizabeth A G ^a   Pereira, Carlos A B ^a   Marques, Amélia P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro Universitario Fundacao e Instituto de Educacao de Osasco (UNIFIEO)   (Brazil)

^c USP ^*

Author keywords

Disability evaluation; Fibromyalgia; Health status indicators; Quality of life; Questionnaires

Indexed keywords

EID: 77958180444     PISSN: 14133555     EISSN: 18099246     Source Type: Journal    
DOI: 10.1590/S1413-35552010005000015     Document Type: Article

References (43)

1. Sigerist HE. Medicine and human welfare. New Haven: Yale University Press; 1941.
2. The World Health Organization. Quality of life assessment: position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403-9.
3. Ferraz MB. Sobrevida e qualidade de vida. Rev Bras Reumatol. 1999;39(9):311.
4. Carmona L, Ballina J, Gabriel R, Laffon A; EPISER study Group. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis. 2001;60(11):1040-5.
5. Wolfe F, Cathey MA. Prevalence of primary and secondary fi brositis. J Rheumatol. 1983;10(6):965-8.
6. Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM, et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol. 2004;31(3):594-7.
7. Assumpcao A, Cavalcante AB, Capela CE, Sauer JF, Chalot SD, Pereira CA, et al. Prevalence of fi bromyalgia in a low socioeconomic status population. BMC Musculoskelet Disord. 2009;10:64.
8. Goldenberg DL, Simms RW, Geiger A, Komaroff AL. High frequency of fi bromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum. 1990;33(3):381-7.
9. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classifi cation of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160-72.
10. Hoffman DL, Dukes EM. The health status burden of people with fi bromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008;62(1):115-26.
11. Tander B, Cengiz K, Alayli G, Ilhanli I, Canbaz S, Canturk F. A comparative evaluation of health related quality of life and depression in patients with fi bromyalgia syndrome and rheumatoid arthritis. Rheumatol Int. 2008;28(9):859-65.
12. White KP, Speechley M, Harth M, Ostbye T. Comparing self-reported function and work disability in 100 community cases of fi bromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis Rheum. 1999;42(1):76-83.
13. Henriksson CM. Longterm effects of fi bromyalgia on everyday life. A study of 56 patients. Scand J Rheumatol. 1994;23(1):36-41.
14. Santos AMB, Assumpcao A, Matsutani LA, Pereira CAB, Lage LV, Marques AP. Depressaoe qualidade de vida em pacientes com fibromialgia. Rev Bras Fisioter. 2006;10(3):317-24.
15. Pagano T, Matsutani LA, Ferreira EA, Marques AP, Pereira CA. Assessment of anxiety and quality of life in fi bromyalgic patients. Sao Paulo Med J. 2004;122(6):252-8.
16. Carville SF, Choy EH. Systematic review of discriminating power of outcome measures used in clinical trials of fi bromyalgia. J Rheumatol. 2008;35(11):2094-105.
17. Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000;25(24):3130-9.
18. Angst F, Verra ML, Lehmann S, Aeschlimann A. Responsiveness of fi ve condition-specific and generic outcome assessment instruments for chronic pain. BMC Med Res Methodol. 2008;8:26.
19. Campolina AG, Ciconelli RM. SF-36 e o desenvolvimento de novas ferramentas de avaliacao de qualidade de vida. [SF-36 and the development of new assessment tools for quality of life]. Acta Reumatol Port. 2008;33(2):127-33.
20. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. A comparison of the responsiveness of different generic health status measures in patients with asthma. Qual Life Res. 2003;12(5):555-63.
21. Burckhardt CS, Clark SR, Bennett RM. The fi bromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18(5):728-33.
22. Marques AP, Santos AMB, Assumpcao A, Matsutani LA, Lage LV, Pereira CAB. Validacao da versao brasileira do Fibromyalgia Impact Questionnaire (FIQ). Rev Bras Reumatol. 2006;46(1):24-31.
23. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005;23(5 Suppl 39): S154-62.
24. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-83.
25. Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JP. Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ. 2009;338:a3006.
26. Ciconelli RM, Ferraz MB, Santos W, Meinao I, Quaresma MR. Traducao para a lingua portuguesa e validacao do questionario generico de avaliacao de qualidade de vida SF-36 (Brasil SF-36) [Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure]. Rev Bras Reumatol. 1999;39:143-50.
27. Reilly PA. Fibromyalgia in the workplace: a 'management' problem. Ann Rheum Dis. 1993;52(4):249-51.
28. Hawley DJ, Wolfe F. Pain, disability, and pain/disability relationships in seven rheumatic disorders: a study of 1,522 patients. J Rheumatol. 1991;18(10):1552-7.
29. Laas K, Roine R, Rasanen P, Sintonen H, Leirisalo-Repo M; HUS QoL Study Group. Healthrelated quality of life in patients with common rheumatic diseases referred to a university clinic. Rheumatol Int. 2009;29(3):267-73.
30. Mas AJ, Carmona L, Valverde M, Ribas B; EPISER Study Group. Prevalence and impact of fi bromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol. 2008;26(4):519-26.
31. Matsutani LA, Marques AP, Ferreira EA, Assumpcao A, Lage LV, Casarotto RA, et al. Effectiveness of muscle stretching exercises with and without laser therapy at tender points for patients with fi bromyalgia. Clin Exp Rheumatol. 2007;25(3):410-5.
32. Marques AP, Ferreira EA, Matsutani LA, Pereira CA, Assumpcao A. Quantifying pain threshold and quality of life of fi bromyalgia patients. Clin Rheumatol. 2005;24(3):266-71.
33. White KP, Nielson WR, Harth M, Ostbye T, Speechley M. Chronic widespread musculoskeletal pain with or without fi bromyalgia: psychological distress in a representative community adult sample. J Rheumatol. 2002;29(3):588-94.
34. Goldenberg DL, Mossey CJ, Schmid CH. A model to assess severity and impact of fi bromyalgia. J Rheumatol. 1995;22(12):2313-8.
35. Birtane M, Uzunca K, Tastekin N, Tuna H. The evaluation of quality of life in fi bromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey. Clin Rheumatol. 2007;26(5):679-84.
36. Neumann L, Berzak A, Buskila D. Measuring health status in Israeli patients with fi bromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum. 2000;29(6):400-8.
37. Berwick DM, Murphy JM, Goldman PA, Ware JE Jr, Barsky AJ, Weinstein MC. Performance of a fi ve-item mental health screening test. Med Care. 1991;29(2):169-76.
38. Ware JE, Kosinski M, Kelle SK. SF-36 Physical and Mental Health Summary Scales: a user's manual. Boston (MA): The Health Institute, New England Medical Center; 1994.
39. Oswald J, Salemi S, Michel BA, Sprott H. Use of the Short-Form-36 Health Survey to detect a subgroup of fi bromyalgia patients with psychological dysfunction. Clin Rheumatol. 2008;27(7):919-21.
40. de Souza JB, Goffaux P, Julien N, Potvin S, Charest J, Marchand S. Fibromyalgia subgroups: profi ling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study. Rheumatol Int. 2009;29(5):509-15.
41. Garratt AM, Ruta DA, Abdalla MI, Russell IT. Responsiveness of the SF-36 and a conditionspecifi c measure of health for patients with varicose veins. Qual Life Res. 1996;5(2):223-34.
42. Gliklich RE, Hilinski JM. Longitudinal sensitivity of generic and specifi c health measures in chronic sinusitis. Qual Life Res. 1995;4(1):27-32.
43. McColl E, Han SW, Barton JR, Welfare MR. A comparison of the discriminatory power of the Infl ammatory Bowel Disease Questionnaire and the SF-36 in people with ulcerative colitis. Qual Life Res. 2004;13(4):805-11.